PLoS One 2021 20;16(1):e0241899. Epub 2021 Jan 20.
St George's, University of London, Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, London, United Kingdom.
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antimicrobial resistance (AMR) and toxicity. We used a pharmaceutical database, IQVIA-Multinational Integrated Data Analysis System (IQVIA-MIDAS®), to estimate sales of antibiotic FDCs from 75 countries in 2015. Read More